O	0	7	Glucose	Glucose	NN	B-NP
O	8	18	catabolism	catabolism	NN	I-NP
O	19	21	in	in	IN	B-PP
B-Cell	22	28	cancer	cancer	NN	B-NP
I-Cell	29	34	cells	cell	NNS	I-NP
O	34	35	:	:	:	O
O	36	50	identification	identification	NN	B-NP
O	51	54	and	and	CC	I-NP
O	55	71	characterization	characterization	NN	I-NP
O	72	74	of	of	IN	B-PP
O	75	76	a	a	DT	B-NP
O	77	83	marked	marked	JJ	I-NP
O	84	94	activation	activation	NN	I-NP
O	95	103	response	response	NN	I-NP
O	104	106	of	of	IN	B-PP
O	107	110	the	the	DT	B-NP
O	111	115	type	type	NN	I-NP
O	116	118	II	II	CD	I-NP
O	119	129	hexokinase	hexokinase	NN	I-NP
O	130	134	gene	gene	NN	I-NP
O	135	137	to	to	TO	B-PP
O	138	145	hypoxic	hypoxic	JJ	B-NP
O	146	156	conditions	condition	NNS	I-NP
O	156	157	.	.	.	O

O	159	162	One	One	CD	B-NP
O	163	165	of	of	IN	B-PP
O	166	169	the	the	DT	B-NP
O	170	174	most	most	RBS	I-NP
O	175	181	common	common	JJ	I-NP
O	182	192	signatures	signature	NNS	I-NP
O	193	195	of	of	IN	B-PP
O	196	202	highly	highly	RB	B-NP
B-Cancer	203	212	malignant	malignant	JJ	I-NP
I-Cancer	213	219	tumors	tumor	NNS	I-NP
O	220	222	is	be	VBZ	B-VP
O	223	228	their	their	PRP$	B-NP
O	229	237	capacity	capacity	NN	I-NP
O	238	240	to	to	TO	B-VP
O	241	251	metabolize	metabolize	VB	I-VP
O	252	256	more	more	JJR	B-NP
O	257	264	glucose	glucose	NN	I-NP
O	265	267	to	to	TO	B-PP
O	268	274	lactic	lactic	JJ	B-NP
O	275	279	acid	acid	NN	I-NP
O	280	284	than	than	IN	B-PP
O	285	290	their	their	PRP$	B-NP
B-Tissue	291	298	tissues	tissue	NNS	I-NP
O	299	301	of	of	IN	B-PP
O	302	308	origin	origin	NN	B-NP
O	308	309	.	.	.	O

B-Cancer	310	319	Hepatomas	Hepatoma	NNS	B-NP
O	320	330	exhibiting	exhibit	VBG	B-VP
O	331	335	this	this	DT	B-NP
O	336	345	phenotype	phenotype	NN	I-NP
O	346	349	are	be	VBP	B-VP
O	350	359	dependent	dependent	JJ	B-ADJP
O	360	362	on	on	IN	B-PP
O	363	366	the	the	DT	B-NP
O	367	371	high	high	JJ	I-NP
O	372	382	expression	expression	NN	I-NP
O	383	385	of	of	IN	B-PP
O	386	390	type	type	NN	B-NP
O	391	393	II	II	CD	I-NP
O	394	404	hexokinase	hexokinase	NN	I-NP
O	404	405	,	,	,	O
O	406	411	which	which	WDT	B-NP
O	412	420	supplies	supply	VBZ	B-VP
O	421	425	such	such	JJ	B-NP
B-Cancer	426	432	tumors	tumor	NNS	I-NP
O	433	437	with	with	IN	B-PP
O	438	446	abundant	abundant	JJ	B-NP
O	447	454	amounts	amount	NNS	I-NP
O	455	457	of	of	IN	B-PP
O	458	465	glucose	glucose	NN	B-NP
O	466	467	6	6	CD	I-NP
O	467	468	-	-	HYPH	I-NP
O	468	477	phosphate	phosphate	NN	I-NP
O	477	478	,	,	,	O
O	479	480	a	a	DT	B-NP
O	481	492	significant	significant	JJ	I-NP
O	493	499	carbon	carbon	NN	I-NP
O	500	503	and	and	CC	I-NP
O	504	510	energy	energy	NN	I-NP
O	511	517	source	source	NN	I-NP
O	518	528	especially	especially	RB	B-ADVP
O	529	534	under	under	IN	B-PP
O	535	542	hypoxic	hypoxic	JJ	B-NP
O	543	553	conditions	condition	NNS	I-NP
O	553	554	.	.	.	O

O	555	559	Here	Here	RB	B-ADVP
O	560	562	we	we	PRP	B-NP
O	563	569	report	report	VBP	B-VP
O	570	574	that	that	IN	B-SBAR
O	575	578	the	the	DT	B-NP
O	579	585	distal	distal	JJ	I-NP
O	586	592	region	region	NN	I-NP
O	593	595	of	of	IN	B-PP
O	596	599	the	the	DT	B-NP
B-Cancer	600	608	hepatoma	hepatoma	NN	I-NP
O	609	613	type	type	NN	I-NP
O	614	616	II	II	CD	I-NP
O	617	627	hexokinase	hexokinase	NN	I-NP
O	628	636	promoter	promoter	NN	I-NP
O	637	645	displays	display	VBZ	B-VP
O	646	655	consensus	consensus	NN	B-NP
O	656	662	motifs	motif	NNS	I-NP
O	663	666	for	for	IN	B-PP
O	667	674	hypoxia	hypoxia	NN	B-NP
O	674	675	-	-	HYPH	B-NP
O	675	684	inducible	inducible	JJ	I-NP
O	685	691	factor	factor	NN	I-NP
O	692	693	(	(	(	O
O	693	696	HIF	HIF	NN	B-NP
O	696	697	-	-	HYPH	B-NP
O	697	698	1	1	CD	I-NP
O	698	699	)	)	)	O
O	700	704	that	that	WDT	B-NP
O	705	712	overlap	overlap	VBP	B-VP
O	713	714	E	E	NN	B-NP
O	714	715	-	-	HYPH	O
O	715	718	box	box	NN	B-NP
O	719	728	sequences	sequence	NNS	I-NP
O	729	734	known	know	VBN	B-VP
O	735	737	to	to	TO	I-VP
O	738	740	be	be	VB	I-VP
O	741	748	related	relate	VBN	I-VP
O	749	751	in	in	IN	B-PP
O	752	757	other	other	JJ	B-NP
O	758	762	gene	gene	NN	I-NP
O	763	772	promoters	promoter	NNS	I-NP
O	773	775	to	to	TO	B-PP
O	776	783	glucose	glucose	NN	B-NP
O	784	792	response	response	NN	I-NP
O	792	793	.	.	.	O

O	794	802	Moreover	Moreover	RB	B-ADVP
O	802	803	,	,	,	O
O	804	806	we	we	PRP	B-NP
O	807	811	show	show	VBP	B-VP
O	812	816	that	that	IN	B-SBAR
O	817	827	subjecting	subject	VBG	B-VP
O	828	839	transfected	transfecte	VBN	B-NP
B-Cell	840	848	hepatoma	hepatoma	NN	I-NP
I-Cell	849	854	cells	cell	NNS	I-NP
O	855	857	to	to	TO	B-PP
O	858	865	hypoxic	hypoxic	JJ	B-NP
O	866	876	conditions	condition	NNS	I-NP
O	877	886	activates	activate	VBZ	B-VP
O	887	890	the	the	DT	B-NP
O	891	895	type	type	NN	I-NP
O	896	898	II	II	CD	I-NP
O	899	909	hexokinase	hexokinase	NN	I-NP
O	910	918	promoter	promoter	NN	I-NP
O	919	925	almost	almost	RB	B-NP
O	926	927	3	3	CD	I-NP
O	927	928	-	-	HYPH	I-NP
O	928	932	fold	fold	RB	B-ADVP
O	932	933	,	,	,	O
O	934	935	a	a	DT	B-NP
O	936	941	value	value	NN	I-NP
O	942	946	that	that	WDT	B-NP
O	947	957	approaches	approach	VBZ	B-VP
O	958	959	7	7	CD	B-NP
O	959	960	-	-	HYPH	I-NP
O	960	964	fold	fold	RB	B-ADVP
O	965	967	in	in	IN	B-PP
O	968	971	the	the	DT	I-PP
O	972	980	presence	presence	NN	I-PP
O	981	983	of	of	IN	I-PP
O	984	991	glucose	glucose	NN	B-NP
O	991	992	.	.	.	O

O	993	1003	Consistent	Consistent	JJ	B-ADJP
O	1004	1008	with	with	IN	B-PP
O	1009	1014	these	these	DT	B-NP
O	1015	1023	findings	finding	NNS	I-NP
O	1024	1026	is	be	VBZ	B-VP
O	1027	1030	the	the	DT	B-NP
O	1031	1040	induction	induction	NN	I-NP
O	1041	1046	under	under	IN	B-PP
O	1047	1054	hypoxic	hypoxic	JJ	B-NP
O	1055	1065	conditions	condition	NNS	I-NP
O	1066	1068	of	of	IN	B-PP
O	1069	1072	the	the	DT	B-NP
O	1073	1076	HIF	HIF	NN	I-NP
O	1076	1077	-	-	HYPH	B-NP
O	1077	1078	1	1	CD	I-NP
O	1079	1086	protein	protein	NN	I-NP
O	1086	1087	.	.	.	O

O	1088	1096	Reporter	Reporter	NN	B-NP
O	1097	1101	gene	gene	NN	I-NP
O	1102	1110	analyses	analysis	NNS	I-NP
O	1111	1115	with	with	IN	B-PP
O	1116	1117	a	a	DT	B-NP
O	1118	1124	series	series	NN	I-NP
O	1125	1127	of	of	IN	B-PP
O	1128	1134	nested	nested	JJ	B-NP
O	1135	1143	deletion	deletion	NN	I-NP
O	1144	1151	mutants	mutant	NNS	I-NP
O	1152	1154	of	of	IN	B-PP
O	1155	1158	the	the	DT	B-NP
B-Cancer	1159	1167	hepatoma	hepatoma	NN	I-NP
O	1168	1172	type	type	NN	I-NP
O	1173	1175	II	II	CD	I-NP
O	1176	1186	hexokinase	hexokinase	NN	I-NP
O	1187	1195	promoter	promoter	NN	I-NP
O	1196	1200	show	show	VBP	B-VP
O	1201	1205	that	that	IN	B-SBAR
O	1206	1207	a	a	DT	B-NP
O	1208	1219	significant	significant	JJ	I-NP
O	1220	1228	fraction	fraction	NN	I-NP
O	1229	1231	of	of	IN	B-PP
O	1232	1235	the	the	DT	B-NP
O	1236	1241	total	total	JJ	I-NP
O	1242	1252	activation	activation	NN	I-NP
O	1253	1261	observed	observe	VBN	B-VP
O	1262	1267	under	under	IN	B-PP
O	1268	1275	hypoxic	hypoxic	JJ	B-NP
O	1276	1286	conditions	condition	NNS	I-NP
O	1287	1296	localizes	localize	VBZ	B-VP
O	1297	1299	to	to	TO	B-PP
O	1300	1303	the	the	DT	B-NP
O	1304	1310	distal	distal	JJ	I-NP
O	1311	1317	region	region	NN	I-NP
O	1318	1323	where	where	WRB	B-ADVP
O	1324	1327	the	the	DT	B-NP
O	1328	1339	overlapping	overlap	VBG	I-NP
O	1340	1343	HIF	HIF	NN	I-NP
O	1343	1344	-	-	HYPH	B-NP
O	1344	1345	1	1	CD	I-NP
O	1345	1346	/	/	SYM	I-NP
O	1346	1347	E	E	NN	I-NP
O	1347	1348	-	-	HYPH	I-NP
O	1348	1351	box	box	NN	I-NP
O	1352	1361	sequences	sequence	NNS	I-NP
O	1362	1365	are	be	VBP	B-VP
O	1366	1373	located	located	JJ	B-ADJP
O	1373	1374	.	.	.	O

O	1375	1382	Finally	Finally	RB	B-ADVP
O	1382	1383	,	,	,	O
O	1384	1389	DNase	DNase	NN	B-NP
O	1390	1391	I	I	CD	I-NP
O	1392	1401	footprint	footprint	NN	I-NP
O	1402	1410	analysis	analysis	NN	I-NP
O	1411	1415	with	with	IN	B-PP
O	1416	1417	a	a	DT	B-NP
O	1418	1425	segment	segment	NN	I-NP
O	1426	1428	of	of	IN	B-PP
O	1429	1432	the	the	DT	B-NP
O	1433	1441	promoter	promoter	NN	I-NP
O	1442	1452	containing	contain	VBG	B-VP
O	1453	1458	these	these	DT	B-NP
O	1459	1467	elements	element	NNS	I-NP
O	1468	1475	reveals	reveal	VBZ	B-VP
O	1476	1479	the	the	DT	B-NP
O	1480	1487	binding	binding	NN	I-NP
O	1488	1490	of	of	IN	B-PP
O	1491	1498	several	several	JJ	B-NP
B-Cellular_component	1499	1506	nuclear	nuclear	JJ	I-NP
O	1507	1515	proteins	protein	NNS	I-NP
O	1515	1516	.	.	.	O

O	1517	1519	In	In	IN	B-PP
O	1520	1527	summary	summary	NN	B-NP
O	1527	1528	,	,	,	O
O	1529	1534	these	these	DT	B-NP
O	1535	1540	novel	novel	JJ	I-NP
O	1541	1548	studies	study	NNS	I-NP
O	1549	1557	identify	identify	VBP	B-VP
O	1558	1561	and	and	CC	I-VP
O	1562	1574	characterize	characterize	VBP	I-VP
O	1575	1576	a	a	DT	B-NP
O	1577	1583	marked	marked	JJ	I-NP
O	1584	1591	glucose	glucose	NN	I-NP
O	1591	1592	-	-	HYPH	B-VP
O	1592	1601	modulated	modulate	VBN	B-NP
O	1602	1612	activation	activation	NN	I-NP
O	1613	1621	response	response	NN	I-NP
O	1622	1624	of	of	IN	B-PP
O	1625	1628	the	the	DT	B-NP
O	1629	1633	type	type	NN	I-NP
O	1634	1636	II	II	CD	I-NP
O	1637	1647	hexokinase	hexokinase	NN	I-NP
O	1648	1652	gene	gene	NN	I-NP
O	1653	1655	to	to	TO	B-PP
O	1656	1663	hypoxic	hypoxic	JJ	B-NP
O	1664	1674	conditions	condition	NNS	I-NP
O	1675	1681	within	within	IN	B-PP
O	1682	1688	highly	highly	RB	B-NP
O	1689	1699	glycolytic	glycolytic	JJ	I-NP
B-Cell	1700	1708	hepatoma	hepatoma	NN	I-NP
I-Cell	1709	1714	cells	cell	NNS	I-NP
O	1714	1715	,	,	,	O
O	1716	1717	a	a	DT	B-NP
O	1718	1726	property	property	NN	I-NP
O	1727	1731	that	that	WDT	B-NP
O	1732	1735	may	may	MD	B-VP
O	1736	1740	help	help	VB	I-VP
O	1741	1747	assure	assure	VB	I-VP
O	1748	1752	that	that	IN	B-SBAR
O	1753	1757	such	such	JJ	B-NP
B-Cell	1758	1763	cells	cell	NNS	I-NP
O	1764	1771	exhibit	exhibit	VBP	B-VP
O	1772	1773	a	a	DT	B-NP
O	1774	1780	growth	growth	NN	I-NP
O	1781	1784	and	and	CC	I-NP
O	1785	1793	survival	survival	NN	I-NP
O	1794	1803	advantage	advantage	NN	I-NP
O	1804	1808	over	over	IN	B-PP
O	1809	1814	their	their	PRP$	B-NP
O	1815	1823	parental	parental	JJ	I-NP
B-Cell	1824	1829	cells	cell	NNS	I-NP
O	1830	1832	of	of	IN	B-PP
O	1833	1839	origin	origin	NN	B-NP
O	1839	1840	.	.	.	O

